2024-03-25 09:11:10 ET
Summary
- Cencora, formerly known as AmerisourceBergen, has achieved a 14.97% YoY increase in total revenue, a 25.38% increase in net income, and a 27.84% increase in free cash flow.
- The company aims to become the underlying healthcare infrastructure for institutions and organizations, expanding its leadership in the healthcare wholesaler and distribution business.
- Cencora is investing in margin-enhancing businesses, leveraging its infrastructure for cost efficiency, and focusing on strategic M&A and in-house investment to support expanded leadership opportunities.
Cencora ( COR )- formerly AmerisourceBergen- is a Conshohocken, Pennsylvania-based drug wholesaler and contract research company with operations across a broad portfolio of specialties, primarily across the US but with a growing international presence....
Read the full article on Seeking Alpha
For further details see:
Cencora Remains Chronically Undervalued, With Material Growth Potential